We are live on !
Find out more
KL
KCK Ltd Portfolio holdings
AUM
$15.1M
Turnover
0%
1-Year Est. Return
30.14%
This Fund
S&P 500
This Quarter Est. Return
-29.29%
1 Year Est. Return
+30.14%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$71.2M
AUM Growth
-$31.3M
(-31%)
Cap. Flow
$0
Cap. Flow % of AUM
Cap. Flow %
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
0.5
years
Top 10 Avg Time Held
0.5
years
Top 20 Avg Time Held
0.5
years
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Sight Sciences
SGHT
$611M
| $42.9M | 60.33% |
4,776,232
| – | – |
2021 Q4
2 quarters
|
|
2
Neuropace
NPCE
$413M
| $27.8M | 39.09% |
5,621,111
| – | – |
2021 Q4
2 quarters
|
|
3
Immunic
IMUX
$106M
| $242K | 0.34% |
6,970
| – | – |
2021 Q4
2 quarters
|
|
4
Rein Therapeutics
RNTX
$48.3M
| $168K | 0.24% |
32,341
| – | – |
2021 Q4
2 quarters
|
|
Similar funds
LM
KCK Ltd's Q2 2022 Portfolio in Review
As of Q2 2022, KCK Ltd held 4 positions worth $71.2M, down 31% from $102M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q2 2022: portfolio turnover was 0%. KCK Ltd opened no new positions and made no exits, leaving the 4-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- KCK Ltd's ten largest holdings make up 100% of its $71.2M portfolio in Q2 2022.
- KCK Ltd opened 0 new positions and closed 0 in Q2 2022.
- KCK Ltd's portfolio value fell 31% quarter-over-quarter to $71.2M.
Based on KCK Ltd's 13F filing for Q2 2022, filed 10 Aug 2022.